Haining Zhou
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 5
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Shoujun Tang (10 shared papers)Shengjie Tang (8 shared papers)Adriaan van Oosterom (3 shared papers)Hang Yan (5 shared papers)Chao Qin (4 shared papers)Jianning Yao (8 shared papers)Xuexiu Zhang (7 shared papers)Haiyang Hu (5 shared papers)
- Journals
- Cells (2 papers)Medicine (2 papers)BMC Cancer (2 papers)Frontiers in Cell and Developmental Biology (1 paper)Chemical Research in Toxicology (1 paper)
- Partner nations
- ChinaJapanNetherlands
In The Last Decade
Haining Zhou
47 papers receiving 869 citations
Haining Zhou's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 158
- Oncology 191
- Pulmonary and Respiratory Medicine 161
- Molecular Biology 271
- Cellular and Molecular Neuroscience 59
Countries citing papers authored by Haining Zhou
This map shows the geographic impact of Haining Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haining Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haining Zhou more than expected).
Fields of papers citing papers by Haining Zhou
This network shows the impact of papers produced by Haining Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haining Zhou. The network helps show where Haining Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Haining Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects Hit paper breakdown → | 2022 | 170 |
| 2 | 2019 | 79 | |
| 3 | 2012 | 73 | |
| 4 | 2022 | 67 | |
| 5 | 1992 | 49 | |
| 6 | 2018 | 48 | |
| 7 | 2021 | 47 | |
| 8 | 2021 | 35 | |
| 9 | 2019 | 34 | |
| 10 | 2018 | 28 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 21 | |
| 13 | 2022 | 19 | |
| 14 | 2018 | 18 | |
| 15 | 2021 | 16 | |
| 16 | 2020 | 14 | |
| 17 | 2022 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2020 | 12 | |
| 20 | 2024 | 11 |
About Haining Zhou
Haining Zhou is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Surgery, Oncology and Molecular Biology, having authored 53 papers that have together received 889 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers), Esophageal Cancer Research and Treatment (5 papers), MicroRNA in disease regulation (5 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers), Electrical and Bioimpedance Tomography (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (158 citations), Oncology (191 citations), Pulmonary and Respiratory Medicine (161 citations), Molecular Biology (271 citations) and Cellular and Molecular Neuroscience (59 citations). Haining Zhou has collaborated with scholars based in China, Japan and Netherlands. Frequent co-authors include Shoujun Tang, Shengjie Tang, Adriaan van Oosterom, Hang Yan, Chao Qin, Jianning Yao, Xuexiu Zhang, Haiyang Hu, Wenchao Zhao and Guang-Shun Yang. Their work appears in journals such as Cells, Medicine, BMC Cancer, Frontiers in Cell and Developmental Biology and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.